Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Coeptis Therapeutics Holdings (COEP) Leases (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Leases data on record, last reported at $29104.0 in Q3 2025.

  • For Q3 2025, Leases fell 58.16% year-over-year to $29104.0; the TTM value through Sep 2025 reached $29104.0, down 58.16%, while the annual FY2024 figure was $59783.0, 38.73% down from the prior year.
  • Leases reached $29104.0 in Q3 2025 per COEP's latest filing, down from $39564.0 in the prior quarter.
  • Across five years, Leases topped out at $97571.0 in Q4 2023 and bottomed at $17925.0 in Q4 2021.
  • Average Leases over 5 years is $52139.9, with a median of $49789.0 recorded in 2025.
  • Peak YoY movement for Leases: soared 228.67% in 2022, then plummeted 58.16% in 2025.
  • A 5-year view of Leases shows it stood at $17925.0 in 2021, then skyrocketed by 228.67% to $58914.0 in 2022, then skyrocketed by 65.62% to $97571.0 in 2023, then tumbled by 38.73% to $59783.0 in 2024, then tumbled by 51.32% to $29104.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $29104.0 in Q3 2025, $39564.0 in Q2 2025, and $49789.0 in Q1 2025.